FR3000403B1 - Composition dermatologique comprenant un inhibiteur de pde7 sous forme solubilisee, son procede de preparation et son utilisation - Google Patents

Composition dermatologique comprenant un inhibiteur de pde7 sous forme solubilisee, son procede de preparation et son utilisation

Info

Publication number
FR3000403B1
FR3000403B1 FR1262925A FR1262925A FR3000403B1 FR 3000403 B1 FR3000403 B1 FR 3000403B1 FR 1262925 A FR1262925 A FR 1262925A FR 1262925 A FR1262925 A FR 1262925A FR 3000403 B1 FR3000403 B1 FR 3000403B1
Authority
FR
France
Prior art keywords
solubilized
preparation
dermatological composition
pde7 inhibitor
pde7
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1262925A
Other languages
English (en)
Other versions
FR3000403A1 (fr
Inventor
Emmanuelle Guillet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to FR1262925A priority Critical patent/FR3000403B1/fr
Priority to PCT/FR2013/053241 priority patent/WO2014102497A1/fr
Publication of FR3000403A1 publication Critical patent/FR3000403A1/fr
Application granted granted Critical
Publication of FR3000403B1 publication Critical patent/FR3000403B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR1262925A 2012-12-28 2012-12-28 Composition dermatologique comprenant un inhibiteur de pde7 sous forme solubilisee, son procede de preparation et son utilisation Expired - Fee Related FR3000403B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1262925A FR3000403B1 (fr) 2012-12-28 2012-12-28 Composition dermatologique comprenant un inhibiteur de pde7 sous forme solubilisee, son procede de preparation et son utilisation
PCT/FR2013/053241 WO2014102497A1 (fr) 2012-12-28 2013-12-20 Composition dermatologique comprenant un inhibiteur de pde7 sous forme solubilisée, son procédé de préparation et son utilisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1262925A FR3000403B1 (fr) 2012-12-28 2012-12-28 Composition dermatologique comprenant un inhibiteur de pde7 sous forme solubilisee, son procede de preparation et son utilisation

Publications (2)

Publication Number Publication Date
FR3000403A1 FR3000403A1 (fr) 2014-07-04
FR3000403B1 true FR3000403B1 (fr) 2015-02-06

Family

ID=47989193

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1262925A Expired - Fee Related FR3000403B1 (fr) 2012-12-28 2012-12-28 Composition dermatologique comprenant un inhibiteur de pde7 sous forme solubilisee, son procede de preparation et son utilisation

Country Status (2)

Country Link
FR (1) FR3000403B1 (fr)
WO (1) WO2014102497A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2433943T3 (da) * 2004-07-01 2013-12-16 Daiichi Sankyo Co Ltd Mellemprodukter til thienopyrazol-derivater med PDE7-inhibitorisk aktivitet
FR2878442B1 (fr) * 2004-11-29 2008-10-24 Aventis Pharma Sa THIENO(2,3-c)PYRAZOLES SUBSTITUES, PROCEDE DE PREPARATION, COMPOSITIONS LES CONTENANT ET UTILISATION

Also Published As

Publication number Publication date
FR3000403A1 (fr) 2014-07-04
WO2014102497A1 (fr) 2014-07-03

Similar Documents

Publication Publication Date Title
BR112015002541A2 (pt) composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente.
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BR112014023937A2 (pt) composição farmacêutica, agente farmacêutico de combinação e método de tratamento
ZA201503753B (en) Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof
SG11201406085TA (en) Method and system for operating winches, and use thereof
ZA201501541B (en) Supported catalyst and active form thereof, and preparation method and use thereof
BR112012018101A2 (pt) aparelho, e método.
BR112012031232A2 (pt) método, dispositivo e uso
HUE037607T2 (hu) Folyékony készítmény biológiai növényvédelemhez, eljárás ennek elõállítására és ennek alkalmazása
ITMI20111404A1 (it) Supporto per articolazioni umane.
BR112012016424A2 (pt) aparelho, e método.
FR2959733B1 (fr) Grue et procede de relevage de la grue.
BR112014026873A2 (pt) método cosmético, composição cosmética e uso.
FR2986795B1 (fr) Composition cosmetique comprenant un compose multifonctionnel, compose et procede de traitement cosmetique
EP2687549A4 (fr) Polymère lipophile fortement ramifié, et composition photopolymérisable le contenant
DK2816947T3 (da) Endoskopisk anordning, særlig til medicinsk brug
PT2928861T (pt) Derivados de aminociclobutano, processo para a sua preparação e a sua utilização como medicamentos
BR112015001843A2 (pt) dispositivo médico, composição de matriz biodegradável e método para tratar um paciente.
EP2924042A4 (fr) Composé bis- -carboline et procédé de préparation, composition pharmaceutique et utilisation associée
BR112015015040A2 (pt) composição sólida ou semissólida, método para a preparação da composição e utilização da composição
EP3037099A4 (fr) Composition pharmaceutique, procédé de préparation et utilisation associés
BR112014007007A2 (pt) método de diferenciação precoce, método de diagnóstico de fibrilação, uso de troponina cardíaca, dispositivo de diferenciação e dispositivo de diagnóstico
EP2937541A4 (fr) Engin de mesure, système de mesure et procédé de mesure
FR2950253B1 (fr) Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
EP2687532A4 (fr) Nouveau dérivé octahydrothiénoquinoline, composition pharmaceutique comprenant le dérivé, et utilisation de ceux-ci

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160831